• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    4.80 Up 0.23(5.03%) 4:00PM EST
    Add to Portfolio
    Prev Close:4.57
    Open:4.56
    Bid:4.05 x 1000
    Ask:5.55 x 100
    1y Target Est:11.60
    Beta:1.86
    Earnings Date:Jan 26 - Jan 30 (Est.)
    Day's Range:4.55 - 4.80
    52wk Range:3.05 - 13.26
    Volume:176,525
    Avg Vol (3m):310,389
    Market Cap:175.72M
    P/E (ttm):N/A
    EPS (ttm):-0.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTKUp 5.03%175.72M
    BIIBUp 2.39%78.61B
    LGNDUp 0.97%1.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.90
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-0.36

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback